Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) Return on Invested Capital (2018 - 2025)

Bicycle Therapeutics (BCYC) has disclosed Return on Invested Capital for 8 consecutive years, with 0.44% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Invested Capital fell 21.0% year-over-year to 0.44%, compared with a TTM value of 0.44% through Sep 2025, down 21.0%, and an annual FY2024 reading of 0.66%, down 6.0% over the prior year.
  • Return on Invested Capital was 0.44% for Q3 2025 at Bicycle Therapeutics, down from 0.37% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.22% in Q1 2022 and bottomed at 0.63% in Q2 2023.
  • Average Return on Invested Capital over 5 years is 0.39%, with a median of 0.41% recorded in 2022.
  • The sharpest move saw Return on Invested Capital plummeted -36bps in 2023, then surged 33bps in 2024.
  • Year by year, Return on Invested Capital stood at 0.25% in 2021, then plummeted by -66bps to 0.41% in 2022, then decreased by -18bps to 0.49% in 2023, then increased by 3bps to 0.47% in 2024, then rose by 7bps to 0.44% in 2025.
  • Business Quant data shows Return on Invested Capital for BCYC at 0.44% in Q3 2025, 0.37% in Q2 2025, and 0.26% in Q1 2025.